Literature DB >> 27984038

Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.

Stéphanie E Boonk1, Willem H Zoutman2, Hein Putter3, Caroline Ram-Wolff4, Moritz Felcht5, Claus-Detlev Klemke6, Annamari Ranki7, Pietro Quaglino8, Sean Whittaker9, Martine Bagot4, Rein Willemze2, Maarten H Vermeer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27984038     DOI： 10.1016/j.jid.2016.10.025

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  4 in total

Review 1.  [Diagnostics of primary cutaneous lymphomas].

Authors:  M Felcht; U Hillen; C-D Klemke
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

Review 2.  Plastin 3 in health and disease: a matter of balance.

Authors:  Lisa Wolff; Eike A Strathmann; Ilka Müller; Daniela Mählich; Charlotte Veltman; Anja Niehoff; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2021-05-23       Impact factor: 9.261

Review 3.  Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.

Authors:  Andrea Moerman-Herzog; Syed J Mehdi; Henry K Wong
Journal:  Cells       Date:  2020-08-29       Impact factor: 6.600

Review 4.  Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma.

Authors:  Ping Zhang; Mingzhi Zhang
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.